Carotid body tumor contemporary management in a high-volume center
Adult
Male
Operative Time
Contrast Media
Carotid Body Tumor
Conservative Treatment
Paraganglioma
03 medical and health sciences
0302 clinical medicine
Risk Factors
Humans
Aged
Retrospective Studies
Aged, 80 and over
Surgical procedures, operative
Radiotherapy
Angiography
Middle Aged
Embolization, Therapeutic
Iopamidol
3. Good health
Survival Rate
Female
Carotid body tumor
Cranial nerve injuries
Vascular Surgical Procedures
DOI:
10.23736/s0021-9509.19.10496-x
Publication Date:
2020-07-27T09:27:53Z
AUTHORS (6)
ABSTRACT
The aim of this study is to report our results with carotid body tumor (CBT) surgical management.Between 2010 and 2018, 100 CBTs (mean age: 48.0 years, range 21-80 years old) were treated in our center. The patients were classified in 3 groups according to the size: group I (<3 cm), group II (3 to 5 cm) and group III (>5 cm).Surgical resection was performed in 88 patients and conservative treatment in 2 cases. Nine patients were treated for bilateral involvement and one of them was also treated again for a relapse. Postoperatively, cranial nerve injury (CNI) was significantly higher in group II [3 (8.3%) vs. 16 (31.4%) vs. 2 (15.4%); P=0.030] with no statistical differences between the CN involved. At univariate analysis for CNI, CBT group (P=0.030), maximum diameter (P=0.046), patients presenting with dysphonia (P=0.035) and dysphagia (P=0.007) and patients suffering from any intraoperative complication (P=0.047) were statistically significant. At multivariate analysis the only significant variable was CBT group II (P=0.016). For blood loss, CBT group III (P<0.001), Shamblin class III (P<0.001), Pulmonary disease (P=0.034) and surgery time (P<0.001) were statistically significant. The follow-up of 79 patients (87.8%) showed a 100% overall survival at median follow-up of 37.7 months (range 2-84.7 months) with freedom from local recurrence of 97.8% (77/79).Surgical resection remains the gold standard to obtain complete recovery, although tumor size is to be considered a risk factor for CNI because large CBTs remain at high risk for CNIs.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (26)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....